HNF1A and diabetes mellitus: In contrast to type 1 diabetes mellitus patients who have a rapid disease onset, HNF1A-MODY carriers represent an interesting and important study group for the study of beta cell apoptosis during disease progression as carriers will ultimately develop diabetes [1].